COVID-19 vaccine developers plan joint safety pledge on approval: Report

▴ covid19-vaccine-developers-plan-joint-safety-pledge-approval-report
The companies would pledge to adhere to high scientific and ethical standards in the conduct of clinical studies and in their manufacturing processes,

Several COVID-19 vaccine developers, including Pfizer Inc, Johnson & Johnson, and Moderna Inc, plan to issue a public pledge not to seek government approval until their vaccine candidates are proven to be safe and effective, the Wall Street Journal reported on Friday.

The companies would pledge to adhere to high scientific and ethical standards in the conduct of clinical studies and their manufacturing processes, the Journal report said, citing the draft of a joint statement that is still being finalized.

The companies might issue the pledge as soon as early next week, the report added, citing two people familiar with the matter.

The news comes amid rising concerns that political pressure ahead of the Nov. 3 election could weigh on the safety and effectiveness of a potential vaccine for the respiratory illness.

White House Press Secretary Kayleigh McEnany said on Thursday that even though the stakes are high for President Donald Trump, who is squaring off against former Vice President Joe Biden, there is no political pressure on the U.S. health regulator to quickly approve a vaccine.

AstraZeneca Plc, Pfizer, and Moderna are among those farthest along in the race to develop vaccines to prevent COVID-19 infection or limit its severity, with its candidates in late-stage clinical trials.

Pfizer, Moderna, and Johnson & Johnson did not immediately respond to Reuter's request for comment.

Tags : #Pledge #COVID-19 #Vaccine #Developers #Approval #Report #Pfizer #AstraZeneca #Moderna

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024
Empowering Patients: The Role of Advocacy in Indian HealthcareMarch 26, 2024
A New Dawn in Heart Surgery: Mitral Valve Repair for 15-Year-Old PatientMarch 26, 2024
Cracking the Code of Extended Fasting: Lessons from a Comprehensive InvestigationMarch 26, 2024
From Lab to Life: Exploring Eating Behaviors with AI WearablesMarch 26, 2024
Invisible Scars Foundation Hosts Disruptive Domestic Violence Stakeholder’s Summit (First Edition) in TelanganaMarch 23, 2024